The pending implementation of the new European chemicals legislation (REACH) will produce the requirement of a lot of additional testing, including bioaccumulation assessment in fish and other aquatic species. Bioconcentration testing is highly animal intensive. Thus alternative test methods have to be developed to reduce the number of test animals or to avoid the use of test animals by using alternative in vitro test systems.
Method and results
The PAMPA system has been developed and widely used in pharmacokinetics research for assessing uptake of pharmaceuticals in the gastrointestinal tract and across other membrane barriers, such as epithelium cells. Very recently, the coapplicant of this project has used PAMPA for the first time to evaluate its potential for assessing passive absorption and elimination in small fish across fish gills. This work is very promising but the method still needs refinement, adjustment of conditions and a wider database before it can be applied as an alternative test method. The PAMPA system is composed of two well-stirred aqueous compartments divided by a microporous filter that is impregnated with a solvent -phospholipids mixture (Fig. 1) . The greatest advantage of PAMPA is that the microporous filter-supported bilayers or the substitute that we are presently using (PDMS) have similar properties to actual biological membranes. Measured permeability correlates well with percent absorption of orally administered drugs that passively permeate intestinal aqueous and lipid barriers. Also the system has the potential for high-throughput testing by using a microtiter plate format, a system that is commercially available in pharmaceutical sciences but needs refinement for use as fish model.
Development of an
Passive uptake across the gill epithelium is not the only determinant factor for overall bioconcentration. Metabolic transformation reactions will also strongly influence the bioconcentration. In a second phase of the proposed project, we plan to include metabolic processes by combining passive membrane permeation and a metabolic degradation assay in vitro using an enzyme cocktail. This metabolic degradation assay is based on the S9 fraction of fish liver, which is another in vitro method that is presently undergoing method development for the validation phase.
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Conclusions and relevance for 3R
Bioconcentration assessment in fish is highly animal and labor intensive. According to the OECD test guideline 305 "Bioconcentration: Flow-through Fish Test" (OECD, 1996) the test is performed during 28 days in two phases -uptake and depuration -with at least 9 sampling points using at least four fish each. Thus a minimum number of 40 fish is required for the determination of one BCF value for one fish species and one chemical. Considering that in the future more chemicals will need to be assessed for their PBT properties (P = persistence, B = bioaccumulation, T = toxicity) due to the implementation of the new European Chemical's legislation, there is an imperative need for alternative methods.
In addition, the presently availably Quantitative StructureActivity Relationship (QSAR) models or partitioning-based bioaccumulation models only cover passive diffusion of hydrophobic chemicals. There is a clear need for new in vitro tests and prediction models that also tackle difficult substances such as ionisable material or readily biodegradable substances, thus lowering overall uptake.
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